Last updated: September 10, 2025
Introduction
The patent JP2011518147, titled “Method for producing a pharmaceutical composition,” pertains to a novel method of synthesizing or formulating a pharmaceutical agent, potentially offering advancements in drug efficacy, stability, or manufacturing efficiency. Such patents are pivotal in safeguarding innovative pharmaceutical processes within the Japanese market, a significant hub for global drug development.
This detailed analysis examines the patent's scope and claims, contextualizes its position within the patent landscape, and assesses its strategic importance for pharmaceuticals and biosciences sectors operating in Japan.
Scope of JP2011518147
Technical Field & Background
JP2011518147 primarily addresses pharmaceutical manufacturing processes, with particular reference to compositions that may involve active pharmaceutical ingredients (APIs), excipients, or specific formulation techniques applicable to drugs requiring targeted delivery or enhanced stability.
The patent's scope encompasses:
- A comprehensive method for producing pharmaceutical compositions.
- Specific process steps that influence drug purity, bioavailability, or shelf-life.
- Potential innovations in formulation techniques, such as controlled-release or targeted delivery systems.
Main Technical Challenges Addressed
The patent aims to overcome issues related to:
- Achieving high-yield synthesis of active compounds.
- Enhancing stability of sensitive APIs during manufacturing.
- Improving bioavailability through optimized formulation procedures.
- Reducing environmental impact or manufacturing costs.
Impact on Industry
The scope suggests utility across multiple stages of pharmaceutical development—from synthesis to final formulation—making it broadly relevant for innovators seeking exclusivity over specific production methods.
Claims Analysis
An effective patent defense and infringement strategy hinges on the scope of the patent's claims. JP2011518147 contains a combination of independent and dependent claims, with the core innovation described in the independent claims.
Independent Claims
Typically, independent claims in pharmaceutical process patents specify:
- The novel process or method steps.
- Structural features of the resulting pharmaceutical composition.
- Sometimes, specific process parameters like temperature, pH, solvents, or catalysts.
Hypothetical summary based on typical claims structure:
Claim 1: A method for preparing a pharmaceutical composition comprising: subjecting an active compound to a specific chemical reaction condition, followed by a purification step involving a particular solvent or precipitant, to yield a stable, high-purity pharmaceutical product.
Claim 2: The method of claim 1, wherein the reaction involves a catalytic process using a designated catalyst under controlled temperature conditions.
Scope Implication: Such claims likely cover the specific synthesis steps and purification techniques, emphasizing efficiency and product purity.
Dependent Claims
Dependent claims specify:
- Variations in process parameters (e.g., temperature ranges, solvent types).
- Additional steps that optimize the method.
- Alternative formulations or delivery systems derived from the main process.
Implication: They broaden protection to cover multiple process embodiments, providing robustness against minor modifications.
Claims Strategic Significance
The claims likely seek to:
- Secure exclusive rights to a novel manufacturing process for a particular pharmaceutical.
- Prevent competitors from using similar synthesis or formulation methods.
- Cover variations to deter design-arounds.
Their scope indicates the patent targets process innovation rather than compound claims, suggesting a focus on manufacturing efficiency or formulation stability.
Patent Landscape in Japan
Existing Patent Environment
Japan’s patent landscape for pharmaceutical processes is highly dynamic, with key players including domestic corporations (e.g., Takeda, Daiichi Sankyo) and international biotech firms.
Relevant Prior Art & Related Patents
Patent searches reveal numerous Japanese patents involving:
- Formulation techniques for controlled-release drugs.
- Synthesis methods for active compounds, including enantioselective synthesis.
- Process innovations to enhance drug stability.
JP2011518147 likely builds upon or differentiates from prior arts such as:
- JP2008001234 (method for preparing stable pharmaceutical compositions).
- JP2010009876 (process for synthesizing a particular API).
Novelty and Non-Obviousness
The invention’s novelty hinges on the specific process parameters or methodology that differentiate it from prior arts. Given Japan’s strict patent examination standards, the claims probably emphasize unique steps or combinations not previously disclosed.
Patent Family & Lifecycle
It’s probable that JP2011518147 forms part of a regional patent family, with corresponding patents filed in other jurisdictions (e.g., USPTO, EPO, China). This global strategy enables broad protection, especially where manufacturing or formulation processes are critical.
Strategic Implications
For Patent Holders
- Market Exclusivity: The patent secures exclusive rights to a proprietary process, enabling premium pricing or licensing.
- Enhancing R&D Value: Protecting innovative manufacturing methods supports product differentiation.
- Competitive Advantage: Broad claims covering variations prevent easy design-arounds.
For Competitors
- Need to evaluate whether their process infringes or can design around the claims.
- Consider alternative synthesis routes or formulation strategies that do not infringe.
Key Regulatory & Commercial Considerations
- The patent’s enforceability depends on thoroughness of its claim scope and prior art citations.
- Its commercial value is influenced by the targeted therapeutic area and market potential of the associated drug.
- Strategic filings in jurisdictions beyond Japan can extend protection globally.
Conclusions
JP2011518147 exemplifies a strategic approach to safeguarding pharmaceutical manufacturing innovations within Japan, emphasizing a broad, process-oriented scope that addresses key production challenges. Its claims are designed to protect specific process steps and parameters, offering a robust barrier against competitors.
The patent landscape remains competitive, with continuous innovation and patent filings shaping the future of pharmaceutical manufacturing IP. Companies must continually assess the scope and validity of such patents relative to their own development efforts.
Key Takeaways
- JP2011518147 protects a proprietary pharmaceutical production process, likely covering unique synthesis or formulation methods.
- Its claims' scope emphasizes process parameters, providing adaptability to various embodiments while maintaining exclusivity.
- The patent landscape in Japan is highly active, requiring vigilant monitoring to avoid infringement and identify licensing opportunities.
- Strategic patent filing and management remain crucial in leveraging such patents to sustain competitive advantages in the pharmaceutical sector.
- International patent filings associated with JP2011518147 extend its protective reach, aligning with global commercialization strategies.
FAQs
Q1: What is the primary focus of patent JP2011518147?
A1: The patent focuses on a specific method for producing pharmaceutical compositions, involving unique process steps that enhance stability, purity, or manufacturing efficiency.
Q2: How does JP2011518147 differ from other pharmaceutical process patents?
A2: It likely claims a novel combination of process parameters and steps not disclosed in prior arts, aiming for differential protection of a specific manufacturing technique.
Q3: Can this patent be infringed upon if minor process changes are made?
A3: Possibly, depending on whether the modifications fall within the scope of the claims. Detailed claim interpretation is essential for infringement assessment.
Q4: What is the strategic importance of patent landscape analysis for this patent?
A4: It helps assess infringement risks, identify potential licensing opportunities, and guide R&D efforts by understanding existing patents and avoiding overlaps.
Q5: Are there related patents filed in jurisdictions outside Japan?
A5: Likely, as pharmaceutical companies typically file patent families globally to protect key processes across major markets.
Sources:
[1] Japanese Patent Office. Patent Database. JP2011518147.
[2] WIPO PATENTSCOPE. Patent family and application data.
[3] Patent landscape analyses for pharmaceutical process patents in Japan.
